Question

Difficulty: HardClinical Preventive Services and Screening

A 1212-month-old boy is brought to the clinic for a routine well-child examination. He was diagnosed with perinatal human immunodeficiency virus (HIV) infection and is currently receiving antiretroviral therapy. His mother reports he has had a mild cough and rhinorrhea for the past 22 days. On physical examination, his temperature is 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), pulse is 120/min120/\text{min}, and respirations are 32/min32/\text{min}. Lung auscultation reveals diffuse bilateral wheezing and mild crackles without increased work of breathing. When asked about his behavior, the mother is concerned because he only specifically says 'mama' and 'dada' and stands alone but cannot walk independently. Recent laboratory results show a CD4+ T-cell percentage of 12%12\%. His immunizations are up to date through the 66-month schedule. Which of the following is the most appropriate next step in management for this patient?

  1. Administer Hepatitis A and pneumococcal conjugate vaccines, advise supportive care for the respiratory symptoms, and reassure the mother regarding his developmentAnswer
  2. B
    Administer the measles, mumps, and rubella (MMR) vaccine, prescribe an albuterol inhaler, and reassure the mother regarding his development
  3. C
    Administer Hepatitis A and pneumococcal conjugate vaccines, advise supportive care for the respiratory symptoms, and refer the child for a comprehensive developmental evaluation
  4. D
    Defer all immunizations until the respiratory symptoms resolve, prescribe an inhaled corticosteroid, and reassure the mother regarding his development
  5. E
    Administer the varicella vaccine, advise supportive care for the respiratory symptoms, and refer the child for a comprehensive developmental evaluation

Answer

The correct management is to administer age-appropriate inactivated vaccines (Hepatitis A and pneumococcal conjugate), provide supportive care for his mild respiratory symptoms, and reassure the mother regarding his normal developmental milestones.
This patient presents for a 1212-month well-child visit. At 1212 months, the standard immunization schedule includes both inactivated vaccines (e.g., pneumococcal conjugate, Hepatitis A, Haemophilus influenzae type b) and live-attenuated vaccines (MMR, Varicella). Because this child has HIV with a CD4+ T-cell percentage below 15%15\%, he has severe immunosuppression. Therefore, all live-attenuated vaccines are absolutely contraindicated. He should still receive his scheduled inactivated vaccines. The presence of a mild acute illness, such as his current viral bronchiolitis, is not a valid reason to defer inactivated vaccines. His bronchiolitis should be managed with supportive care alone (no albuterol or steroids). Finally, his developmental milestones (standing alone, saying 'mama' and 'dada' specifically) are perfectly age-appropriate, so the mother simply requires reassurance.

Step-by-Step Solution

1
Evaluate the patient's immune status and determine eligibility for 1212-month vaccines.
The patient has HIV with a CD4+ T-cell percentage of 12%12\%, indicating severe immunosuppression.
In HIV-infected children under 55 years old, a CD4+ T-cell percentage below 15%15\% represents severe immunosuppression, making live-attenuated vaccines (like MMR and Varicella) strictly contraindicated. However, inactivated vaccines (like Hepatitis A and pneumococcal conjugate) should be administered on schedule.
2
Assess the patient's acute respiratory presentation to determine if it affects vaccine administration or requires pharmacologic intervention.
The patient has symptoms consistent with mild viral bronchiolitis (wheezing, mild crackles, rhinorrhea, no increased work of breathing).
Mild acute illness without high fever is not a contraindication to administering scheduled inactivated vaccines. Viral bronchiolitis is self-limiting and managed with supportive care; bronchodilators and inhaled corticosteroids are not indicated.
3
Analyze the patient's developmental milestones for his age (1212 months).
The ability to specifically say 'mama' and 'dada' and stand alone independently are entirely normal milestones for a 1212-month-old.
Since the child is meeting his 1212-month milestones, parental reassurance is the only indicated action regarding development. No early intervention or developmental referral is needed.

Key Concept

Administration of live-attenuated vaccines is contraindicated in pediatric patients with severe immunosuppression (e.g., HIV with CD4+ T-cell percentage < 15%15\%), but inactivated vaccines should be given on schedule regardless of concurrent mild acute illness.
Estimated Time:1m 30s
Rate this question